{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:57:25Z","timestamp":1740142645794,"version":"3.37.3"},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"abstract":"<jats:p>SUMMARY  OBJECTIVES: To evaluate the treatment of wheezing and exacerbation of asthma in a pediatric emergency unit (ED), comparing it to that recommended by the guidelines for this purpose.  METHODS: Descriptive cross-sectional study through medical records survey of children and adolescents (0\u201315 years of age) who received medication for wheezing or asthma exacerbation from January to April 2015 in the ED. The selected treatment was compared to that recommended by the guidelines, being analyzed the variables related to the medication (number and dose of short-acting \u03b22 agonist, associated or not with anticholinergic, oral or parenteral corticosteroid) and the length of stay in ED (\u22641 h, \u22658 h and hospital admission).  RESULTS: One-thousand eleven patients were selected with 56.7% between 3 and 15 years and 56% male. Although the selected drugs were in accordance with what was recommended, errors were observed in relation to dose, drug of choice, and method and time of use with the most frequent finding being incorrect dose (short-acting \u03b22 agonist: 66% and ipratropium bromide: 95.2%).  CONCLUSION: The level of use of the measures recommended by the guidelines was low but compatible with other studies, leading to an increased risk of treatment failure and higher costs. Despite wide dissemination, the established concepts have not been sufficiently incorporated into clinical practice, suggesting the need for more effective educational actions for this process to occur.<\/jats:p>","DOI":"10.1590\/1806-9282.66.9.1270","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T18:50:50Z","timestamp":1601578250000},"page":"1270-1276","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of treatment of the exacerbation of asthma and wheezing in a pediatric emergency department"],"prefix":"10.1590","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4847-1277","authenticated-orcid":false,"given":"Francisco de Assis","family":"Pereira Filho","sequence":"first","affiliation":[{"name":"Centro Universit\u00e1rio Sa\u00fade ABC,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-0871","authenticated-orcid":false,"given":"Roseli Oselka Saccardo","family":"Sarni","sequence":"additional","affiliation":[{"name":"Centro Universit\u00e1rio Sa\u00fade ABC,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3052-0723","authenticated-orcid":false,"given":"Neusa Falbo","family":"Wandalsen","sequence":"additional","affiliation":[{"name":"Centro Universit\u00e1rio Sa\u00fade ABC,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(97)07302-9","article-title":"Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1590\/S0103-05822014000100018","article-title":"Asthma in children and adolescents in Brasil: contribution of the International Study of Asthma and Allergies in Childhood (ISAAC)","volume":"32","author":"Sol\u00e9 D","year":"2014","journal-title":"Rev Paul Pediatr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4168\/aair.2016.8.1.22","article-title":"Prevalence, Severity, and Treatment of Recurrent Wheezing During the First Year of Life: A Cross-Sectional Study of 12,405 Latin American Infants","volume":"8","author":"Mallol J","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref4","first-page":"341","article-title":"ISAAC - Brazilian Group. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3","volume":"82","author":"Sol\u00e9 D","year":"2006","journal-title":"J Pediatr (Rio J)"},{"key":"ref5","first-page":"164","article-title":"Prevalence and severity of wheezing in the first year of life in the city of Santo Andr\u00e9, Brasil","volume":"32","author":"Ferreira IC","year":"2014","journal-title":"Rev Paul Pediatr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1590\/S1806-37132006001100002","article-title":"IV Diretrizes Brasileiras para o Manejo da Asma","volume":"32","year":"2006","journal-title":"J Bras Pneumol"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/625829","article-title":"Asthma mortality inequalities in Brasil: Tolerating the unbearable","author":"Souza-Machado C","year":"2012","journal-title":"Scientific World J"},{"key":"ref8","first-page":"584","article-title":"Acute asthma management in children: knowledge of the topic among health professionals at teaching hospitals in the city of Recife, Brasil","volume":"37","author":"Lustosa GM","year":"2011","journal-title":"J Bras Pneumol"},{"key":"ref9","article-title":"Diretrizes da Associa\u00e7\u00e3o Brasileira de Alergia e Imunologia e Sociedade Brasileira de Pediatria para sibil\u00e2ncia e asma no pr\u00e9-escolar","volume":"2018","author":"Chong Neto HJ","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"volume-title":"Global Initiative for Asthma \u2013 GINA","year":"2014","series-title":"Global Strategy for Asthma Management and Prevention","key":"ref10"},{"key":"ref11","first-page":"S1","article-title":"Diretriz da Sociedade Brasileira de Pneumologia e Tisiologia para o Manejo da Asma","volume":"38","year":"2012","journal-title":"J Bras Pneumol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1590\/S0034-89102002000400006","article-title":"Fatores de risco para hospitaliza\u00e7\u00e3o de crian\u00e7as e adolescentes asm\u00e1ticos","volume":"36","author":"Lasmar L","year":"2002","journal-title":"Rev. Sa\u00fade P\u00fablica [online]"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/(SICI)1099-0496(200004)29:4<250::AID-PPUL3>3.0.CO;2-4","article-title":"Risk factors for exacerbations and hospital admissions in asthma of early childhood","volume":"29","author":"Wever-Hess J","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archpedi.155.9.1057","article-title":"Reasons for pediatrician nonadherence to asthma guidelines","volume":"155","author":"Cabana MD","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref15","article-title":"Factors associated with failure of emergency department management in children with acute moderate or severe asthma: a prospective, multicentre, cohort study","volume":"20","author":"Ducharme FM","year":"2016","journal-title":"Lancet Respir Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1590\/S1806-37132006000500004","article-title":"Fatores de risco para readmiss\u00e3o hospitalar de crian\u00e7as e adolescentes asm\u00e1ticos","volume":"32","author":"Lasmar L","year":"2006","journal-title":"J. Bras Pneumol [online]"},{"key":"ref17","first-page":"108","article-title":"Conhecimento sobre asma de pediatras de hospitais p\u00fablicos do Rio de Janeiro","volume":"2","author":"Cordeiro NGB","year":"2018","journal-title":"Arq asma Alerg Imunol"},{"key":"ref18","first-page":"5","article-title":"Crise aguda de asma em crian\u00e7as na emerg\u00eancia: estamos seguindo as diretrizes?","volume":"2","author":"Chong Neto HJ","year":"2018","journal-title":"Arq asma Alerg Imunol"},{"key":"ref19","first-page":"7","article-title":"Comparison between the drug treatment used in children up to five years of age treated in an emergency room and the guidelines established in the III Brazilian Consensus on Asthma Management","volume":"33","author":"Santos AP","year":"2007","journal-title":"J Bras Pneumol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpeds.2007.09.033","article-title":"Effect of an integrated care pathway on acute asthma\/wheeze in children attending hospital: cluster randomized trial","volume":"152","author":"Cunningham S","year":"2008","journal-title":"J Pediatr"},{"key":"ref21","article-title":"Custos diretos e indiretos da asma: revis\u00e3o de literatura","author":"Damasceno E","year":"2012","journal-title":"Rev. Bras. Alerg. Imunopatol"},{"key":"ref22","article-title":"Custo total do tratamento da crise aguda de asma em crian\u00e7as utilizando diferentes dispositivos inalat\u00f3rios","author":"Cardozo CA","year":"2006","journal-title":"Rev Bras Alerg Imunopatol"},{"issue":"8","key":"ref23","article-title":"Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children","author":"Griffiths B","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"ref24","article-title":"Inhaled anticholinergics and short-acting (2)-agonists versus short-acting (2)-agonists alone for children with acute asthma in hospital","author":"Vezina K","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"series-title":"Portaria-1317- DE 25 DE NOVEMBRO DE","key":"ref25"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ramb\/v66n9\/1806-9282-ramb-66-09-1270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T02:31:33Z","timestamp":1611455493000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302020000901270&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["S0104-42302020000901270"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.66.9.1270","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"type":"electronic","value":"1806-9282"},{"type":"print","value":"0104-4230"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}